Contact
Please use this form to send email to PR contact of this press release:
Achaogen Announces ZEMDRI® (plazomicin) Pivotal Phase 3 Study Results Published in the New England Journal of Medicine
TO:
Please use this form to send email to PR contact of this press release:
Achaogen Announces ZEMDRI® (plazomicin) Pivotal Phase 3 Study Results Published in the New England Journal of Medicine
TO: